Literature DB >> 31086333

The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc.

Han Dong1,2,3, Nicholas M Adams4,5, Yichi Xu6, Jin Cao7,8,9, David S J Allan10, James R Carlyle11,12, Xi Chen7,8,9, Joseph C Sun4,5,13, Laurie H Glimcher14,15,16.   

Abstract

Natural killer (NK) cells are critical mediators of host immunity to pathogens. Here, we demonstrate that the endoplasmic reticulum stress sensor inositol-requiring enzyme 1 (IRE1α) and its substrate transcription factor X-box-binding protein 1 (XBP1) drive NK cell responses against viral infection and tumors in vivo. IRE1α-XBP1 were essential for expansion of activated mouse and human NK cells and are situated downstream of the mammalian target of rapamycin signaling pathway. Transcriptome and chromatin immunoprecipitation analysis revealed c-Myc as a new and direct downstream target of XBP1 for regulation of NK cell proliferation. Genetic ablation or pharmaceutical blockade of IRE1α downregulated c-Myc, and NK cells with c-Myc haploinsufficency phenocopied IRE1α-XBP1 deficiency. c-Myc overexpression largely rescued the proliferation defect in IRE1α-/- NK cells. Like c-Myc, IRE1α-XBP1 also promotes oxidative phosphorylation in NK cells. Overall, our study identifies a IRE1α-XBP1-cMyc axis in NK cell immunity, providing insight into host protection against infection and cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31086333      PMCID: PMC6588410          DOI: 10.1038/s41590-019-0388-z

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  45 in total

1.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

2.  Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.

Authors:  Karsten Krug; Eric J Jaehnig; Shankha Satpathy; Lili Blumenberg; Alla Karpova; Meenakshi Anurag; George Miles; Philipp Mertins; Yifat Geffen; Lauren C Tang; David I Heiman; Song Cao; Yosef E Maruvka; Jonathan T Lei; Chen Huang; Ramani B Kothadia; Antonio Colaprico; Chet Birger; Jarey Wang; Yongchao Dou; Bo Wen; Zhiao Shi; Yuxing Liao; Maciej Wiznerowicz; Matthew A Wyczalkowski; Xi Steven Chen; Jacob J Kennedy; Amanda G Paulovich; Mathangi Thiagarajan; Christopher R Kinsinger; Tara Hiltke; Emily S Boja; Mehdi Mesri; Ana I Robles; Henry Rodriguez; Thomas F Westbrook; Li Ding; Gad Getz; Karl R Clauser; David Fenyö; Kelly V Ruggles; Bing Zhang; D R Mani; Steven A Carr; Matthew J Ellis; Michael A Gillette
Journal:  Cell       Date:  2020-11-18       Impact factor: 41.582

Review 3.  Mechanisms, regulation and functions of the unfolded protein response.

Authors:  Claudio Hetz; Kezhong Zhang; Randal J Kaufman
Journal:  Nat Rev Mol Cell Biol       Date:  2020-05-26       Impact factor: 94.444

4.  A novel XBP1 variant is highly enriched in cancer tissues and is specifically required for cancer cell survival.

Authors:  Yongwang Zhong; Wenjing Yan; Jingjing Ruan; Mike Fang; Rena G Lapidus; Shaojun Du; Shengyun Fang
Journal:  Biochem Biophys Res Commun       Date:  2021-05-24       Impact factor: 3.322

Review 5.  Endoplasmic reticulum stress signals in the tumour and its microenvironment.

Authors:  Xi Chen; Juan R Cubillos-Ruiz
Journal:  Nat Rev Cancer       Date:  2020-11-19       Impact factor: 60.716

Review 6.  Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy.

Authors:  Chloe Choi; David K Finlay
Journal:  Stem Cell Res Ther       Date:  2021-06-05       Impact factor: 6.832

Review 7.  Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance.

Authors:  Javier Traba; Michael N Sack; Thomas A Waldmann; Olga M Anton
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 8.  Natural killer cells in antiviral immunity.

Authors:  Niklas K Björkström; Benedikt Strunz; Hans-Gustaf Ljunggren
Journal:  Nat Rev Immunol       Date:  2021-06-11       Impact factor: 53.106

9.  The Unfolded Protein Response in Immune Cells as an Emerging Regulator of Neuroinflammation.

Authors:  Dominique Fernández; Antonia Geisse; Jose Ignacio Bernales; Alonso Lira; Fabiola Osorio
Journal:  Front Aging Neurosci       Date:  2021-06-11       Impact factor: 5.750

10.  Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy.

Authors:  Yuting Tang; Qian Xu; Liang Hu; Xiaomei Yan; Xiaomin Feng; Asumi Yokota; Weinan Wang; Di Zhan; Durga Krishnamurthy; David E Ochayon; Lijun Wen; Li Huo; Huimin Zeng; Yingwan Luo; L Frank Huang; Mark Wunderlich; Jiwang Zhang; Eric Vivier; Jianfeng Zhou; Stephen N Waggoner; Gang Huang
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.